Jaguar Health Corp (JAGX) - Long-Term Debt to Capital Coefficient

Jaguar Health, Inc. (JAGX) specializes in developing natural medications for gastrointestinal therapy. The share price history on the GURU.Markets platform, where the indicator stands at 0.41, reflects the business dynamics. The company adheres to ESG principles when sourcing raw materials in the tropics to protect ecosystems. Meanwhile, management under Lisa Conte is flexibly transforming the financial model to fund scientific research.

This ratio determines the proportion of long-term liabilities within the equity structure, measuring the degree of financial leverage. For Jaguar Health, Inc. (JAGX), which faces chronic losses, this balance is critical, as excessive debt coupled with depleting resources poses a bankruptcy risk. The trend of long-term loans relative to equity reflects the company's ability to fund drug development without the risk of default. An increase in this metric signals a dangerous rise in the debt load, while consistently low values confirm the business's resilience to external shocks.